Pembrolizumab (Keytruda, Merck) has picked up another indication — this time for the first-line treatment of unresectable ...

Keytruda plus chemo has been approved for unresectable advanced or metastatic malignant pleural mesothelioma based on ...

The following is a summary of “Pleural gradient does not reflect the superimposed pressure in patients with class III obesity ...

The FDA has approved Keytruda in combination with pemetrexed and platinum chemotherapy, as first-line Tx of unresectable advanced or metastatic malignant pleural mesothelioma.

Pleura is a thin membrane that covers the surface of the lungs and the inside of the chest wall, encompassing the pleural space. It is normal for this space to have some fluid (about 10 to 20 ml), as ...

Malignant pleural mesothelioma is cancer of the lining of the lungs caused by asbestos exposure. Symptoms include chest pain, trouble breathing, and a persistent cough. The average life expectancy for ...

What is a pleural biopsy? A biopsy is a procedure done to remove a tissue sample from the body so it can be examined. The pleura is a double layer of membranes that surrounds the lungs. A pleural ...

Drug major Merck & Co., Inc. (MRK) announced Wednesday that the U.S. Food and Drug Administration has approved its anti-PD-1 therapy ...

Merck & Co. has won its first U.S. approval for use of its blockbuster cancer drug Keytruda in patients with malignant pleural mesothelioma, a rare cancer that grows in the membrane that lines the ...

Sacituzumab govitecan is under clinical development by Gilead Sciences and currently in Phase II for Malignant Pleural Mesothelioma.